Federal Contractor Profile
Ridgeback Biotherapeutics LP
Federal contracting record: $34M obligated across 2 awards from 1 agencies, FY 2019–2025.
Company Profile
Parent UEI (Unique Entity Identifier)
J486UJLMAKB5
CAGE Code
8B1C9
Address
3162 COMMODORE PLAZA STE 3E, MIAMI, FL, 331335815
First Federal Award
Sep 5, 2019
Most Recent Award
Jun 7, 2022
Federal Sales Analytics
Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.
Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).
Top Federal Agencies
- $34M
Department of Health and Human Services
100.0% of total obligations
Top NAICS Activity
- $34M
541713
RESEARCH AND DEVELOPMENT IN NANOTECHNOLOGY
2 awards
Recent Federal Awards
| Date | Agency | NAICS | Description | Amount |
|---|---|---|---|---|
| Apr 19, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541713 | CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA. | $1.5M |
| Oct 29, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541713 | CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA. | $3.4M |
| Aug 14, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541713 | CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA. | $1.4M |
| Feb 4, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541713 | CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA. | $3.0M |
| Mar 19, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541713 | CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA. | $11M |
| Sep 5, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541713 | CMC EFFORTS FOR MAB114 DEVELOPMENT FOR THE TREATMENT OF EBOLA. | $14M |
Related Contractors
Other companies active in NAICS 541713 — RESEARCH AND DEVELOPMENT IN NANOTECHNOLOGY.
Track Ridgeback Biotherapeutics LP Recompetes Before They Post
Mindy monitors Ridgeback Biotherapeutics LP's active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.
Get Free Recompete Alerts